CAS 1178884-53-1

Formel: C5H4BrClN2O

InChl: InChI=1S/C5H4BrClN2O/c1-9-5(10)3(6)2-4(7)8-9/h2H,1H3

InChI Key: HXCPMIRSWJJTGV-UHFFFAOYSA-N

SMILES: CN1C(=O)C(=CC(=N1)Cl)Br

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one

CAS: 1178884-53-1

Formel: C₅H₄BrClN₂O

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 223.4551

Ref: IN-DA00HEAU

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one

CAS: 1178884-53-1

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one

Formel: C₅H₄BrClN₂O

Reinheit: 98%

Molekulargewicht: 223.46

Ref: 54-OR1043434

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one

CAS: 1178884-53-1

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one

Formel: C₅H₄BrClN₂O

Reinheit: 95%

Molekulargewicht: 223.46

Ref: IN-DG280331

4-BROMO-6-CHLORO-2-METHYLPYRIDAZIN-3(2H)-ONE

CAS: 1178884-53-1

Formel: C₅H₄BrClN₂O

Reinheit: 95%

Molekulargewicht: 223.45

Ref: 10-F304831

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one

CAS: 1178884-53-1

4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one is a research chemical that has shown potential for various applications. It has been studied for its intraocular properties and its ability to enhance the levels of carotenoids in the eye. This compound can be used in the form of dichloride for intravitreal injections, where it has demonstrated efficacy in reducing inflammation and inhibiting the production of tumor necrosis factor-alpha (TNF-α). Additionally, 4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one has been found to have antioxidant properties, potentially due to its interaction with eugenol and endothelial growth factors. Furthermore, this compound has shown promise in promoting dopamine release and stimulating cellulose growth. It is also being explored as an anti-VEGF agent and has been investigated for its potential use in synthetic cannabinoids and biomass activation. Overall, 4-B

Formel: C₅H₄N₂OClBr

Reinheit: Min. 95%

Molekulargewicht: 223.46 g/mol

Ref: 3D-DXB88453